Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis

BACKGROUND: Dipeptidyl peptidase-IV (DPP-IV) inhibitors, the enhancers of incretin are used for the treatment of diabetes. The non-glycaemic actions of these drugs (under developmental stage) also proved that repurposing of these molecules may be advantageous for other few complicated disorders like...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalichem, Nehru Sai Suresh, Jupudi, Srikanth, Yasam, Venkata Ramesh, Basavan, Duraiswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research Article (Experimental)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642699/
https://www.ncbi.nlm.nih.gov/pubmed/34756798
http://dx.doi.org/10.1016/j.jaim.2021.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642699/
https://www.ncbi.nlm.nih.gov/pubmed/34756798
http://dx.doi.org/10.1016/j.jaim.2021.08.008

Ejemplares similares